Nutreco co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.
UK-based mycoprotein producer Enough raised €42m ($49.8m) today in a series B round co-led by animal nutrition specialist Nutreco and Olympic Investments, the private investment arm of the Onassis Foundation. The round also featured Axa IM Alts, which is part of insurance group Axa and which invested through its Axa Impact Fund-Climate & Biodiversity vehicle,…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.